LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

ELI LILLY & Co

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$1240.34−16.69 (-1.33%)

Close on Oct 19, 2026

Market cap: $1.11T
P/E (TTM): 41.6
Dividend yield: 0.50%

Earnings

Next report expected Oct 29, 2026, before market open (estimated from past report dates)

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q2 FY2026 Ended Jun 30, 2026	Aug 5, 2026	Before market open	$23.00B	$7.94	$8.38
Q1 FY2026 Ended Mar 31, 2026	Apr 30, 2026	Before market open	$19.80B	$8.26	$8.55
Q4 FY2025 Ended Dec 31, 2025	Feb 4, 2026	Before market open	$19.29B	$7.39	$7.54
Q3 FY2025 Ended Sep 30, 2025	Oct 30, 2025	Before market open	$17.60B	$6.21	$7.02
Q2 FY2025 Ended Jun 30, 2025	Aug 7, 2025	Before market open	$15.56B	–	–
Q1 FY2025 Ended Mar 31, 2025	May 1, 2025	Before market open	$12.73B	$3.06	$3.34
Q4 FY2024 Ended Dec 31, 2024	Jan 14, 2025	Before market open	$13.50B	–	–
Q3 FY2024 Ended Sep 30, 2024	Oct 30, 2024	Before market open	$11.44B	$1.07	$1.18
Q2 FY2024 Ended Jun 30, 2024	Aug 8, 2024	Before market open	$11.30B	$3.28	$3.92
Q1 FY2024 Ended Mar 31, 2024	Apr 30, 2024	Before market open	–	–	–
Q4 FY2023 Ended Dec 31, 2023	Feb 6, 2024	Before market open	–	–	–

Company guidance

Outlook given with results on Aug 5, 2026, compared with the previous outlook

Measure	Period	Guidance	vs. prior
Earnings per Sharenon-GAAP	full year	$35.50 to $36.50	Lowered
Performance Marginnon-GAAP	full-year 2026	49% to 50.5%	Raised
RevenueGAAP	2026 full-year	$85.00B to $87.00B	New

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Eli Lilly filed with the SEC

Aug 5, 2026, 7:05 AM ET
Refer to: Megan MacCauley; [email protected] (Media)
Results of operations · EX-99.1 to Form 8-K
Apr 30, 2026, 7:03 AM ET
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media)
Results of operations · EX-99 to Form 8-K
Feb 4, 2026, 7:05 AM ET
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media)
Results of operations · EX-99.1 to Form 8-K
Oct 30, 2025, 7:03 AM ET
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media)
Results of operations · EX-99.1 to Form 8-K
Aug 7, 2025, 7:05 AM ET
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media)
Results of operations · EX-99.1 to Form 8-K
May 1, 2025, 7:03 AM ET
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media)
Results of operations · EX-99.1 to Form 8-K
Feb 6, 2025, 7:05 AM ET
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media)
Results of operations · EX-99.1 to Form 8-K
Jan 14, 2025, 9:05 AM ET
Refer to: Carrie Munk; [email protected] ; 317-416-2393 (Media)
Results of operations · EX-99.1 to Form 8-K
Oct 30, 2024, 7:05 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 374-1878 (Media)
Results of operations · EX-99.1 to Form 8-K
Aug 8, 2024, 7:04 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 374-1878 (Media)
Results of operations · EX-99.1 to Form 8-K
Apr 30, 2024, 7:04 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Feb 6, 2024, 7:04 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Nov 2, 2023, 7:02 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Aug 8, 2023, 7:01 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Apr 27, 2023, 7:02 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.01 to Form 8-K
Feb 2, 2023, 7:13 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Dec 13, 2022, 7:03 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99 to Form 8-K
Nov 1, 2022, 7:03 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Aug 4, 2022, 7:05 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Apr 28, 2022, 7:05 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Feb 3, 2022, 7:08 AM ET
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media)
Results of operations · EX-99.1 to Form 8-K
Dec 15, 2021, 7:05 AM ET
Molly McCully; [email protected] ; 317-478-5423 (Media)
Results of operations · EX-99.1 to Form 8-K
Oct 26, 2021, 7:06 AM ET
Refer to: Molly McCully; [email protected]; (317) 478-5423 (Media)
Results of operations · EX-99.1 to Form 8-K
Dec 15, 2020, 7:27 AM ET
Refer to: Mark Taylor; [email protected]; (317) 276-5795 (Media)
Results of operations · EX-99.1 to Form 8-K
Dec 17, 2019, 8:46 AM ET
Mark Taylor; [email protected]; (317) 276-5795 (Media)
Results of operations · EX-99.1 to Form 8-K
Oct 23, 2019, 7:28 AM ET
Refer to: Mark Taylor; [email protected]; (317) 276-5795 (Media)
Results of operations · Executive or director change · Other events · EX-99.1 to Form 8-K
Oct 23, 2019, 7:28 AM ET
EX-99.2 to Form 8-K
Results of operations · Executive or director change · Other events · EX-99.2 to Form 8-K
Dec 19, 2018, 1:04 PM ET
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
Dec 13, 2017, 5:07 PM ET
Lauren Zierke; [email protected] ; 317-277-6524 (Media)
Results of operations · EX-99.1 to Form 8-K
Oct 22, 2015, 6:25 AM ET
Refer to: Lauren Zierke; [email protected]; (317) 277-6524 (Media)
Results of operations · EX-99.1 to Form 8-K
Jul 23, 2015, 8:26 AM ET
Refer to: Lauren Zierke; [email protected]; (317) 277-6524 (Media)
Results of operations · EX-99 to Form 8-K
Oct 23, 2014, 6:41 AM ET
Refer to: (317) 276-5795 - Mark Taylor (Media)
Results of operations · EX-99.1 to Form 8-K
Oct 23, 2013, 6:36 AM ET
Refer to: (317) 276-5795 - Mark Taylor (Media)
Results of operations · EX-99.1 to Form 8-K
Aug 9, 2012, 8:06 AM ET
PRESS RELEASE DATED AUGUST 9, 2012
Results of operations · EX-99.1 to Form 8-K
Jul 25, 2012, 6:30 AM ET
Refer to: (317) 276-5795 – Mark E. Taylor (Media)
Results of operations · EX-99 to Form 8-K
Apr 25, 2012, 6:45 AM ET
Refer to: (317) 276-5795 – Mark E. Taylor (Media)
Results of operations · EX-99 to Form 8-K
Jan 31, 2012, 6:30 AM ET
Refer to: (317) 276-5795 – Mark E. Taylor (Media)
Results of operations · EX-99.1 to Form 8-K
Jan 5, 2012, 9:26 AM ET
Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
Results of operations · EX-99.1 to Form 8-K/A
Jan 5, 2012, 8:01 AM ET
Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
Results of operations · EX-99.1 to Form 8-K
Oct 20, 2011, 6:30 AM ET
Refer to: (317) 276-5795 – Mark E. Taylor (Media)
Results of operations · EX-99.1 to Form 8-K

Where these numbers come from

Parsed from the XBRL in Eli Lilly's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Oct 16, 1997
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LLY.

Revenue growth49.6% · median 6.4%

Gross margin83.4% · median 72.2%

Net margin33.5% · median 8.3%

Company	Revenue	Growth
LLY	$79.67B	+49.6%
MRK	$66.57B	+4.6%
ABBV	$64.39B	+10.4%
PFE	$63.70B	-0.2%
ABT	$46.59B	+8.1%
NVO	–	–

Company

Next earnings (est.): Oct 29, 2026, before open
Exchange: NYSE
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 50,000
Held by institutions: 83.7%
Auditor: Ernst & Young LLP
SEC CIK: 59478

Advertisement
300 × 250